По вашему запросу найдено документов: 174

Страница 1 из 18

ОСОБЕННОСТИ ФИЗИЧЕСКОГО РАЗВИТИЯ ШКОЛЬНИКОВ И СТУДЕНТОВ, ЗАНИМАЮЩИХСЯ ФИЗКУЛЬТУРОЙ И СПОРТОМ
FEATURES OF PHYSICAL DEVELOPMENT OF SCHOOLCHILDREN AND STUDENTS ENGAGED IN PHYSICAL EDUCATION AND SPORTS
АГАФОНОВ, А.И., ЗУЛЬКАРНАЕВ, Т.Р., ПОВАРГО, Е.А., СТЕПАНОВ, Е.Г., АХМЕТШИНА, Р.А., ХУСАИНОВ, А.Э., Agafonov, A. I., Zulkarnaev, T.R., Povargo, E.A., Stepanov, E.G., Akhmetshina, R.A., Khusainov, A.E. (2020)
DAILY ROUTINE
Лечение и профилактика самопроизвольного выкидыша в условиях реальной клинической практики. Проспективное мультицентровое исследование
Treatment and prevention of miscarriage in real clinical practice. A prospective multicenter study
Podzolkova, N.M., Skvortsova, M.Yu., Spiridonova, N.V., Guryeva, V.A., Kuleshov, V.M., Kravchenko, E.N., Korzhuk, O.V., Katkova, N.Yu., Arzhanova, O.N., Bespalova, O.N., Kapustin, R.V., Kukarskaya, I.I., Bolshakova, T.G., Sakhautdinova, I.V., Zulkarneeva, E.M., Malyshkina, A.I., Nazarov, S.B., Подзолкова, Н.М., Скворцова, М.Ю., Спиридонова, Н.В., Гурьева, В.А., Кулешов, В.М., Кравченко, Е.Н., Коржук, О.В., Каткова, Н.Ю., Аржанова, О.Н., Беспалова, О.Н., Капустин, Р.В., Кукарская, И.И., Большакова, Т.Г., Сахаутдинова, И.В., Зулкарнеева, Э.М., Малышкина, А.И., Назаров, С.Б. (2023)
ОЦЕНКА УРОВНЯ ФУНКЦИОНАЛЬНОЙ АКТИВНОСТИ В ПЕРИОД МАКСИМАЛЬНОЙ КОСТНОЙ МАССЫ
EVALUATION OF THE LEVEL OF FUNCTIONAL ACTIVITY IN THE PERIOD OF MAXIMUM BONE MASS
Т. Б. Минасов, T. B. Minasov, Р. А. Саубанов, R. A. Saubanov, Р. М. Вахитов-Ковалевич, R. M. Vakhitov-Kovalevich, В. А. Фадеев, V. A. Fadeev, Р. Ф. Файзуллин, R. F. Faizullin, Н. Н. Аслямов, N. N. Aslyamov (Медицинский вестник Башкортостана, №6, 2018)
Comparing the efficacy and safety of weekly somatrogon with daily somatropin to treat children with growth hormone deficiency: a plain language summary of publication
Deal, Cheri L., Steelman, Joel, Vlachopapadopoulou, Elpis, Stawerska, Renata, Silverman, Lawrence A., Phillip, Moshe, Kim, Ho-Seong, Ko, CheolWoo, Malievskiy, Oleg, Cara, Jose F., Roland, Carl L., Taylor, Carrie Turich, Valluri, Srinivas Rao, Wajnrajch, Michael P., Pastrak, Aleksandra, Miller, Bradley S. (2024)
The efficacy of weekly somatrogon injections was no different from that of daily somatropin
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
Deal, C, Steelman, J, Vlachopapadopoulou, E, Stawerska, R, Silverman, LA;, Phillip, M, Kim, HS, Ko, CW, Malievskiy, O, Cara, JF, Roland, CL, Taylor, CT, Valluri, SR, Wajnrajch, MP, Pastrak, A, Miller, BS (2022)
the efficacy and safety of once-weekly somatrogon with once-daily somatropin in prepubertal children with GHD
A RANDOMIZED PHASE 2 STUDY OF LONG-ACTING TRANSCON GH VS DAILY GH IN CHILDHOOD GH DEFICIENCY
Chatelain, Pierre, Malievskiy, Oleg, Radziuk, Klaudziya, Senatorova, Ganna, Abdou, Magdy O., Vlachopapadopoulou, Elpis, Skorodok, Yulia, Peterkova, Valentina, Leff, Jonathan A., Beckert, Michael (2017)
the pharmacokinetics, pharmacodynamics, safety, and efficacy of weekly TransCon GH to that of daily GH in prepubertal
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
Context: Daily injections are required for growth hormone (GH) replacement therapy, which may cause
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievsky, Oleg, Mauras, Nelly, Valluri, Srinivas Rao, Pastrak, Aleksandra, Rosenfeld, Ron (2023)
. once-daily GH (Genotropin®) was initiated, after which participants could enroll into an open
12-Month Effects of Once-Weekly and Twice-Monthly Administration of Hybrid Fc-Fused Human Growth Hormone, GX-H9, Treatment in Pediatric with GHD Deficiency
Malieyskiy, O., Mykola, A., Nataliya, Z., Bolshova, E.V., Senatorova, G., Oroszlan, G., Skorodok, J., Peterkova, V., Nataliya, C., Sorokman, T., Yang, S., Lee, J.E., Muzsnai, A., Hwang, J.S., Lee, S.Y., Choi, Y.J., Ji, H.J., Woo, J., Sung, Y.C. (2018)
daily of Genotropin® for up to 24 months. Among fifty-six pediatric GH naïve GHD subjects randomized
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic
Santomauro, DF, Herrera, AMM, Shadid, J, Zheng, P, Ashbaugh, C, Pigott, DM, Abbafati, C, Adolph, C, Amlag, JO, Aravkin, AY, Bang-Jensen, BL, Idrisov, B, Group Author (2021)
, daily SARS-CoV-2 infection rate, and daily excess mortality rate). We then used this model to estimate

Страница 1 из 18

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год